Deep vein thrombosis complications

Deep-vein thrombosis (DVT), or the condition were blood clots are formed in the lower extremities, usually in the lower legs, can cause complications that may lead to a pulmonary embolism and post-thrombotic syndrome.

DVT may lead to a serious pulmonary embolism (PE) if a piece of a blood clot breaks off and blocks the blood vessels in the lungs. A pulmonary embolism can be deadly if it is not treated as it damages the lungs.

DVT may also lead to post-thrombotic syndrome if it damages valves in the veins, causing blood concentrations to form in the lower leg. Long-term pain, swelling, and leg ulcers may occur to people with post-thrombotic syndrome.

Unfortunately, deep-vein thrombosis is a serious health issue that has been linked with the use of Yasmin birth control pills. If you have suffered such a complication after using these dangerous birth control pills, our legal team at Williams Kherkher may be able to help you take legal action for your suffering. Learn more about taking legal action by calling 800-761-3187.

FDA releases report stating Depakote can decrease IQ

The U.S. Food and Drug Administration (FDA) released a drug safety communication yesterday reporting that the anti-seizure medication Depakote is now believed to decrease IQ scores in children born to women who took the drug while pregnant.

Although Depakote had previously been found to cause a number of other serious birth defects in babies, such as Spina Bifida, club foot, scoliosis, club hands/fingers, cleft lip, and more, the Neurodevelopmental Effects of Antiepileptic Drugs study was recently completed and found that children who were exposed to Depakote in the womb had lower IQ levels by the age of six compared to children who were not exposed to the drug.

As a result of this study, the FDA has recommended that Depakote’s label include stronger warnings regarding using the drug during pregnancy and plans to alter the warning category for use in preventing migraines from a class “D” to a class “X.” This change reflects the increased danger Depakote poses, as the FDA now warns that rather than being possibly acceptable for preventing migraines despite its dangers, Depakote is now considered to have a risk that “clearly outweighs any possible benefit.”

Despite being prescribed to treat various health concerns, Depakote has been shown to be extremely dangerous to pregnant women and their children. If you have a child who now suffers from a birth defect related to Depakote use during pregnancy, speak with the lawyers at Williams Kherkher about pursuing legal action by callingĀ (888) 220-0640.

John Eddie Williams and John Boundas to Speak at TTLA Pharmaceutical and Medical Device Seminar

John Eddie Williams and John Boundas will be featured speakers at the first TTLA (Texas Trial Lawyers Association) Seminar dedicated solely to pharmaceutical and medical device litigation on April 25th and 26th. John Eddie and John are proud to join other TTLA Legends to discuss and debate a variety of mass tort topics that are central to this important and constantly-changing area of the law. For more information on this event, visitĀ


1 2
SEO for Lawyers